Valbiotis SA (FR:ALVAL) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Valbiotis SA, a French scientific research lab, has released its monthly voting rights and share capital data, showing a total of 15,794,596 shares and 16,435,425 exercisable voting rights as of September 30, 2024. The company, known for developing dietary supplements aimed at preventing metabolic disorders leading to cardiovascular diseases, emphasizes its innovative approach utilizing both terrestrial and marine plants. Valbiotis prides itself on collaborations with top academic centers and has financial backing from the European Union, with its products set for licensing agreements internationally and direct marketing in France.
For further insights into FR:ALVAL stock, check out TipRanks’ Stock Analysis page.